Showing results (71-80 of 221) with videos related to
Sort By:
Pageof 23
The Surgical Clinics of North America|February 1, 1978
Intensive surgical and chemotherapeutic management of advanced ovarian cancerC T Griffiths, A F FullerCancer|October 1, 1987
Rhabdomyosarcoma of the uterine cervix. Sarcoma botryoidesE Brand, J S Berek, R K Nieberg, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
Cytoreductive surgery for ovarian cancer: quality assessmentA H Brand, P A DiSilvestro, J Sehouli, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancerS Memarzadeh, S B Lee, J S Berek, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Tumour markersG J Rustin, M E van der Burg, J S BerekEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 1996
Mixed mesodermal sarcoma of the ovary in a young patientJ M Fowler, L Nathan, R K Nieberg, et al.Cancer Research|October 15, 1988
Intraperitoneal administration of human recombinant interferon-alpha in patients with ovarian cancer: effects on lymphocyte phenotype and cytotoxicityA Lichtenstein, C Spina, J S Berek, et al.Pediatrics|April 1, 1987
Is intrauterine growth retardation a risk factor for child abuse?J M Leventhal, A Berg, S A EgerterLancet (London, England)|October 7, 2000
Intergenerational continuity of child physical abuse: how good is the evidence?I O Ertem, J M Leventhal, S DobbsInvestigational New Drugs|May 1, 1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group studyW P McGuire, J A Blessing, J S Berek, et al.Pageof 23